Company profile
bringing gene therapy to kidney patients -
bringing gene therapy to kidney patients -
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Nov 2021 to 30 Apr 2023
58,000 individuals with end-stage kidney disease in the UK are at risk of dying from kidney failure. There are not enough donor kidneys, transplanted organs often only last a few years, and dialysis strongly disrupts patient's lives and is very expensive to the economy. Severe kidney diseases are caused by single gene mutations. Alport Syndrome is a relat...
